This review addresses on the most intensely studied biological targets in the body – type 1 angiotensin receptors. Particular attention is focused on receptor structure and its interaction with various intracellular signal molecules. Data on long-known and newly created ligands able to influence AT1 receptors are presented. The individual structural fragments of AT1 antagonist molecules with functional significance for this type of activity are described. The review includes a brief analysis of the potentials for the clinical use of AT1 antagonists in a number of pathological states additional to the registered indications, including arterial hypertension, chronic heart failure, and nephropathy in type 2 diabetes mellitus. These results from the discovery of additional aspects of the mechanism of action of antagonists and their ability to produce effects such as neuroprotective and anti-inflammatory actions, as well as various organ-protective properties.
Similar content being viewed by others
References
L. Hunyady and K. J. Catt, Molec. Endocrinol., 20(5), 953 – 970 (2006).
P. K. Mehta and K. K. Griendling, Am. J. Physiol. Cell. Physiol., 292(1), 82 – 97 (2007).
R. M. Touyz, Braz. J. Med. Biol. Res., 37(8), 1263 – 1273 (2004).
C. Dasgupta and L. Zhang, Drug. Discov. Today, 16(1), 22 – 34 (2011).
D. T. Dihn, A. G. Frauman, C. I. Jonston, and M. E. Fabiani, Clin. Sci., 100(5), 481 – 492 (2001).
S. V. Terent’eva, E. N. Komarova, T. N. Sapozhnikova, et al., Khim-Farm. Zh., 40(12), 54 – 56 (2006); Pharm. Chem. J., 40(12), (2006).
M. De Gasparo, K. J. Catt, T. Inagami, et al., Pharmacol. Rev., 52(3), 415 – 472 (2000).
C. A. Lemarie and E. L. Schiffrin, J. Renin-Angiotensin-Aldosterone Syst., 11(1), 19 – 31 (2010).
O. V. Shevchenko, A. A. Svistunov, V. B. Borodulin, et al., Saratov. Nauch.-Med. Zh., 7(1), 83 – 87 (2011).
M. Jira, E. Zavodna, N. Honzikova, et al., Physiol. Res., 59(4), 517 – 528 (2010).
P. P. Van Geel, Y. M. Pinto, A. A. Voors, et al., Hypertension, 35(3), 717 – 721 (2000).
S. Miura, S. S. Karnik, and K. Saku, J. Renin-Angiotensin-Aldosterone Syst., 12(1), 1 – 7 (2011).
L. Yan, B. J. Holleran, P. Lavigne, et al., J. Biol. Chem., 285(4), 2284 – 2293 (2010).
D. F. Guo, Y. L. Sun, P. Hamet, and T. Inagami, Cell Res., 11(3), 165 – 180 (2001).
M. Yamada, M. Kushibiki, T. Osanai, et al., Cardiovasc. Res., 79(1), 169 – 178 (2008).
J. L. Hansen, J. Theilade, S. Haunso, and S. P. Sheikh, J. Biol. Chem., 279(23), 24108 – 24115 (2004).
S. Guimaraes and H. Pinheiro, Cardiovasc. Res., 67(2), 208 – 215 (2005).
E. Kaschina and T. Unger, Blood Pressure, 12(2), 70 – 88 (2003).
N. Asano, T. Ogura, Y. Mimura, et al., Res. Common. Mol. Pathol. Pharmacol., 100(2), 161 – 170 (1998).
H. M. Siragy, Am. J. Kidney. Dis., 36(3) Suppl. 1, 4 – 9 (2000).
H. M. Siragy and R. M. Carey, Am. J. Nephrol., 31(6), 541 – 550 (2010).
P. D. Bell and J. Peti-Peterdi, J. Am. Soc. Nephrol., 10, Supplement 11, 225 – 229 (1999).
P. R. Saxena, J. Cardiovasc. Pharmacol., 19, (Suppl. 6), 80 – 88 (1992).
A. I. De Gois Queiroz, C. D. Medeiros, B. M. Ribeiro, et al., Med. Hypotheses, 80(3), 259 – 263 (2013).
M. Paul, A. Poyan Mehr, and R. Kreutz, Physiol. Rev., 86(3), 747 – 803 (2006).
E. G. Krause, S. J. Melhorn, J. F. Davis, et al., Endocrinology, 149(12), 6416 – 6424 (2008).
M. Macova, J. Pavel, and J. M. Saavedra, Brain. Res., 1250, 130 – 140 (2009).
J. M. Saaverda, M. Viswanathan, and K. Shigematsu, Eur. J. Pharmacol., 235(2 – 3), 301 – 303 (1993).
A. M. Allen, H. Yamada, and F. A. Mendelsohn, Int. J. Cardiol., 28(1), 25 – 33 (1990).
L. A. Sechi, C. A. Griffin, E. F. Grady, et al., Circ. Res., 71(6), 1482 – 1489 (1992).
A. A. Spasov, D. S. Yakovlev, T. M. Bukatina, A. A. Brigadirova, Byull. Éksperim. Biol. Med., 158(7), 128 – 130 (2014).
S. A. Atlas, J. Manag. Care Pharm., 13(8) Suppl. B, 9 – 20 (2007).
S. Higuchi, H. Ohtsu, H. Suzuki, et al., Clin. Sci., 112(8), 417 – 428 (2007).
Y. Numaguchi, M. Ishii, R. Kubota, et al., Arterioscler. Thromb. Vasc. Biol., 29(12), 2102 – 2108 (2009).
J. W. Wright, S. Mizutani, and J. W. Harding, Int. J. Hypertens., 2012, Article ID 124758, 1 – 12 (2012).
S. D. Kivlighn, W. R. Huckle, G. J. Zingaro, et al., Am. J. Physiol., 268(3), 820 – 823 (1995).
Y. Wan, C. Wallinder, B. Johansson, et al., J. Med. Chem., 47(6), 1536 – 1546 (2004).
M. Alterman, J. Renin-Angiotensin-Aldosterone Syst., 11(1), 57 – 66 (2010).
P. A. Van Zwieten, Neth. Heart J., 14(11), 381 – 387 (2006).
G. K. Aulakh, R. K. Sodhi, and M. Singh, Life Sci., 81(8), 615 – 639 (2007).
N. V. Zakharova, S. R. Kuz’mina-Krutetskaya, Sistem. Gipertenzii, 8(3), 10 – 16 (2011).
A. M. Shilov, I. V. Eremina, Trudnyi Patsient, 9(7), 26 – 32 (2011).
A. L. Vertkin, E. V. Adonina, E. I. Zvyagintseva, et al., Rus. Med. Zh., 17(8), 589 – 594 (2009).
V. V. Fomin, M. M. Kurashov, Klin. Nefrol., No. 4, 63 – 70 (2009).
C. M. Ferrario, J. Renin-Angiotensin-Aldosterone Syst., 7(1), 3 – 14 (2006).
G. Agelis, K. Kelaidonis, A. Resvani, et al., Molecules, 18(7), 7510 – 7532 (2013).
P. Jezko and M. Remko, Abstrs. of 2nd Meeting of the Paul Ehrlich MedChem Euro-PhD Network, Slovenia (2012), Abstr. O-6, p. 28.
A. Jain, S. C. Chaturverdi, and R. Sharma, Int. J. Pharm. Pharm. Sci., 3(Suppl. 5), 541 – 546 (2011).
X. Z. Guo, L. Shi, R. Wang, et al., Bioorg. Med. Chem., 16(24), 10301 – 10310 (2008).
V. A. Anisimova, A. A. Spasov, I. E. Tolpygin, et al., Khim-Farm. Zh., 44(7), 7 – 13 (2010); Pharm. Chem. J., 44(7), 345 – 351 (2010).
V. A. Anisimova, I. E. Tolpygin, A. A. Spasov, et al., Khim-Farm. Zh., 46(6), 3 – 8 (2012); Pharm. Chem. J., 46(6), 399 – 404 (2012).
A. A. Spasov, D. S. Yakovlev, Khim-Farm. Zh., 47(8), 3 – 8 (2013); Pharm. Chem. J., 47(8) (2013).
H. K. Chopra and N. C. Nanda, Textbook of Cardiology (A Clinical and Historical Perspective), JP Medical Ltd, New Delhi (2013), p. 65.
Y. H. Chi, H. J. Lee, J. H. Kim, et al., Biol. Pharm. Bul., 36(7), 1208 – 1215 (2013).
F. Yamaki, T. Arai, M. Aoyama, et al., J. Pharmacol. Sci., 122(1), 28 – 33 (2013).
M. Ojima, H. Igata, M. Tanaka, et al., J. Pharmacol. Exp. Ther., 336(3), 801 – 808 (2011).
P. Balakumar and N. Mahadevan, Int. J. Rec. Adv. Pharm. Res., 2, 11 – 13 (2011).
A. R. De Caterina, A. R. Harper, and F. Cuculi, Vasc. Health Risk Manag., 8, 299 – 305 (2012).
T. W. Kurtz and T. Kajiya, Vasc. Health Risk Manag., 8, 133 – 143 (2012).
J. H. Kim, J. H. Lee, S. H. Paik, et al., Arch. Pharm. Res., 35(7), 1123 – 1126 (2012).
J. B. Park, K. C. Sung, S. M. Kang, and E. J. Cho, Am. J. Cardiovasc. Drugs, 13(1), 47 – 56 (2013).
S. Ryu, J. S. Shin, Y. W. Cho, et al., Biol. Pharm. Bul., 36(3), 467 – 474 (2013).
Yu. N. Belenkov, R. G. Oganov (red.), Cardilogy. National Guidelines: Brief Edition [in Russian], GÉOTAR-Media, Moscow (2012), pp. 320 – 324.
S. V. Nedogoda, A. S. Salasyuk, T. A. Chalyabi, et al., Sistemnye Gipertenzii, 10(2), 27 – 33 (2013).
S. V. Nedogoda, Ter. Arkhiv, 83(10), 45 – 48 (2011).
A. A. Bova, Med. Novosti, 1 6, 11 – 15 (2009).
I. Taguchi, S. Toyoda, K. Takano, et al., Hypertens. Res., 36(7), 608 – 613 (2013).
V. Zidek, P. Mlejnek, M. Simakova, et al., Am. J. Hypertens., 26(6), 829 – 835 (2013).
A. C. Montezano, A. Nguyen Dinh Cat, F. J. Rios, and R. M. Touyz, Cur. Hypertens. Rep., 16(6), 16:431 (2014).
C. Savoia and E. L. Schiffrin, Clin. Sci., 112(7), 375 – 384 (2007).
J. M. Saavedra, E. Sanchez-Lemus, and J. Benicky, Psychoneuroendocrinology, 36(1), 1 – 18 (2011).
T. V. Lanx, Z. Ding, P. P. Ho, et al., J. Clin. Invest., 120(8), 2782 – 2794 (2010).
K. D. Silveira, F. M. Coelho, A. T. Vieira, et al., Peptides, 46, 53 – 63 (2013).
M. I. Phillips and E. M. de Oliveira, J. Mol. Med., 86(6), 715 – 722 (2008).
J. M. Saavedra, Clin. Sci., 123(10), 567 – 590 (2012).
J. Wang, T. Pang, T. Hafko, et al., Neuropharmacology, 79, 249 – 261 (2014).
J. W. Wright and J. W. Harding, Pflügers Arch., 465(1), 133 – 151 (2013).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Spasov, A.A., Yakovlev, D.S. & Brigadirova, A.A. Angiotensin AT1 Receptors and Their Ligands (Review). Pharm Chem J 51, 1–8 (2017). https://doi.org/10.1007/s11094-017-1546-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-017-1546-y